Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

This study has been completed.

Study NCT00122304 Information provided by Alexion Pharmaceuticals

First Received: July 19, 2005 Last Updated: February 20, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2006
Estimated Primary Completion Date:	No date given